Feb 9 (Reuters)-
D.Western Therapeutics Institute Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2023 Dec 31, 2022 Dec 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 427 mln 411 mln 400 mln
(+4.0 pct) (-0.1 pct) (-6.5 pct)
Operating loss 735 mln loss 255 mln
Recurring loss 728 mln loss 241 mln loss 1.45
Net loss 853 mln loss 386 mln loss 1.45
EPS loss 26.85 yen loss 13.05 yen loss 45.13 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T